Article
DNA methylation at birth within the promoter of ANRIL predicts markers of cardiovascular risk at 9 years.
Clinical epigenetics - 1 Jan 2016
Murray Robert, Bryant Jennifer, Titcombe Phil, Barton Sheila J, Inskip Hazel, Harvey Nicholas C, Cooper Cyrus, Lillycrop Karen, Hanson Mark, Godfrey Keith M
Abstract excerpt
AIMS: Antisense non-coding RNA in the INK4 locus (ANRIL) fixed genetic variants have consistently been linked with coronary heart disease (CHD) risk. We investigated relationships between perinatal ANRIL promoter DNA methylation and CHD risk markers in children aged 9 years. Genetic variants in the non-coding RNA ANRIL identify it as an important CHD risk locus. Increasing evidence suggests that the early life...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
